Skip to main content
SpringerLink
Log in

Pregnancy in Breast Cancer Survivors

  • Chapter
  • First Online:
Diseases of the Breast during Pregnancy and Lactation

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1252))

Abstract

Safety of pregnancy occurring after breast cancer treatment has been studied largely, but it is still debatable. These studies have generally showed that overall and disease-free survival in breast cancer survivors with subsequent pregnancy is not less than those without future pregnancy . Also, breast cancer survivors treated with chemotherapy , radiation therapy, or both had no increased risk of congenital anomalies, single gene disorders, or chromosomal syndromes in their offspring. However, it appears that the incidence of preterm labor, low birth weight, and fetal anomalies is higher in these cases.

These issues as well as safe time interval from breast cancer treatment to pregnancy , safe contraceptive method after breast cancer, counseling about pregnancy in survivors, and how to follow up the patient for breast cancer recurrence during pregnancy are discussed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917

    Article  CAS  PubMed  Google Scholar 

  2. DeSantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64(1):52–62

    Article  PubMed  Google Scholar 

  3. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378(9793)a:771–784

    Google Scholar 

  4. Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381(9869):805–816

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Gray RG, Rea D, Handley K, Bowden SJ, Perry P, Earl HM et al (2013) aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer. J Clin Oncol 31(18-suppl):5

    Article  Google Scholar 

  6. Reichman BS, Green KB (1994) Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects. J Natl Cancer Inst Monogr 16:125–129

    Google Scholar 

  7. Del Mastro L, Catzeddu T, Venturini M (2006) Infertility and pregnancy after breast cancer: current knowledge and future perspectives. Cancer Treat Rev 32(6):417–422

    Article  PubMed  Google Scholar 

  8. Mueller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR (2003) Childbearing and survival after breast carcinoma in young women. Cancer 98(6):1131–1140

    Article  PubMed  Google Scholar 

  9. Sankila R, Heinävaara S, Hakulinen T (1994) Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”. Am J Obstet Gynecol 170(3):818–823

    Article  CAS  PubMed  Google Scholar 

  10. von Schoultz E, Johansson H, Wilking N, Rutqvist LE (1995) Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 13(2):430–434

    Article  Google Scholar 

  11. Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, Gelber R, Goldhirsch A (2011) Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat 129(2):309–317

    Article  PubMed  Google Scholar 

  12. Blakely LJ, Buzdar AU, Lozada JA, Shullaih SA, Hoy E, Smith TL et al (2004) Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 100(3):465–469

    Article  PubMed  Google Scholar 

  13. Stensheim H, Cvancarova M, Møller B, Fosså SD (2011) Pregnancy after adolescent and adult cancer: a population-based matched cohort study. Int J Cancer 129(5):1225–1236

    Article  CAS  PubMed  Google Scholar 

  14. Rippy EE, Karat IF, Kissin MW (2009) Pregnancy after breast cancer: the importance of active counseling and planning. Breast 18(6):345–350

    Article  CAS  PubMed  Google Scholar 

  15. Azim HA, Peccatori FA, De Azambuja E, Piccart MJ (2011) Motherhood after breast cancer: searching for la dolce vita. Expert Rev Anticancer Ther 11(2):287–298

    Article  PubMed  Google Scholar 

  16. Cooper DR, Butterfield J (1970) Pregnancy subsequent to mastectomy for cancer of the breast. Ann Surg 171(3):429–433

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Valachis A, Tsali L, Pesce LL, Polyzos NP, Dimitriadis C, Tsalis K et al (2010) Safety of pregnancy after primary breast carcinoma in young women: a meta-analysis to overcome bias of healthy mother effect studies. Obstet Gynecol Surv 65(12):786–793

    Article  PubMed  Google Scholar 

  18. Petrek JA (1994) Pregnancy safety after breast cancer. Cancer 74(1-Suppl):528–531

    Article  CAS  PubMed  Google Scholar 

  19. Kroman N, Jensen MB, Melbye M, Wohlfahrt J, Mouridsen HT (1997) Should women be advised against pregnancy after breast-cancer treatment? Lancet 350(9074):319–322

    Article  CAS  PubMed  Google Scholar 

  20. Kopeika J, Bhaduri M, Kugadas A, Reddy N, Shewbridge A, Mukherji D, Sandri I, Mansi J (2019) Planned and unplanned pregnancies in breast cancer survivors. Breast 46:75–80

    Article  PubMed  Google Scholar 

  21. Ives A, Saunders C, Bulsara M, Semmens J (2007) Pregnancy after breast cancer: population based study. BMJ 334(7586):194

    Article  PubMed  Google Scholar 

  22. Kroman N, Jensen MB, Wohlfahrt J, Ejlertsen B (2008) Pregnancy after treatment of breast cancer—a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol 47(4):545–549

    Article  PubMed  Google Scholar 

  23. Kranick JA, Schaefer C, Rowell S, Desai M, Petrek JA, Hiatt RA et al (2010) Is pregnancy after breast cancer safe? Breast J 16(4):404–411

    PubMed  PubMed Central  Google Scholar 

  24. Azim HA Jr, Santoro L, Pavlidis N, Gelber S, Kroman N, Azim H et al (2011) Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer 47(1):74–83

    Article  PubMed  Google Scholar 

  25. Córdoba O, Bellet M, Vidal X, Cortés J, Llurba E, Rubio IT et al (2012) Pregnancy after treatment of breast cancer in young women does not adversely affect the prognosis. Breast 21(3):272–275

    Article  PubMed  Google Scholar 

  26. Hartman EK, Eslick GD (2016) The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis. Breast Cancer Res Treat 160(2):347–360

    Article  CAS  PubMed  Google Scholar 

  27. Largillier R, Savignoni A, Gligorov J, Chollet P, Guilhaume MN, Spielmann M et al (2009) Prognostic role of pregnancy occurring before or after treatment of early breast cancer patients aged< 35 years: a GET (N) a Working Group analysis. Cancer 115(22):5155–5165

    Article  PubMed  Google Scholar 

  28. Azim HA Jr, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L et al (2013) Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J Clin Oncol 31(1):73

    Article  PubMed  Google Scholar 

  29. Nye L, Rademaker A, Gradishar WJ (2017) Breast Cancer outcomes after diagnosis of hormone-positive breast cancer and subsequent pregnancy in the tamoxifen era. Clin Breast Cancer 17(4):e185–e189

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Lambertini M, Kroman N, Ameye L, Cordoba O, Pinto A, Benedetti G et al (2017) Long-term safety of pregnancy following breast cancer according to estrogen receptor status. J Natl Cancer Inst 110(4):426–429

    Article  PubMed Central  Google Scholar 

  31. de Bree E, Makrigiannakis A, Askoxylakis J, Melissas J, Tsiftsis DD (2010) Pregnancy after breast cancer. A comprehensive review. J Surg Oncol 101(6):534–542

    Article  PubMed  Google Scholar 

  32. Russo J, Moral R, Balogh GA, Mailo D, Russo IH (2005) The protective role of pregnancy in breast cancer. Breast Cancer Res 7(3):131–142

    Article  PubMed  PubMed Central  Google Scholar 

  33. Siwko SK, Dong J, Lewis MT, Liu H, Hilsenbeck SG, Li Y (2008) Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells—implications for pregnancy-induced protection against breast cancer. Stem Cells 26(12):3205–3209

    Article  PubMed  PubMed Central  Google Scholar 

  34. D’Ambrosio V, Vena F, Di Mascio D, Faralli I, Musacchio L, Boccherini C, Brunelli R, Piccioni MG, Panici PB, Giancotti A (2019) Obstetrical outcomes in women with history of breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 178:485–492

    Article  PubMed  Google Scholar 

  35. Byrne J, Rasmussen SA, Steinhorn SC, Connelly RR, Myers MH, Lynch CF et al (1998) Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 62:45–52

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Dodds L, Marrett LD, Tomkins DJ, Green B, Sherman G (1993) Case-control study of congenital anomalies in children of cancer patients. BMJ 307(6897):164–168

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Green DM, Fiorello A, Zevon MA, Hall B, Seigelstein N (1997) Birth defects and childhood cancer in offspring of survivors of childhood cancer. Arch Pediatr Adolesc Med 151:379–383

    Article  CAS  PubMed  Google Scholar 

  38. Chiarelli AM, Marrett LD, Darlington GA (2000) Pregnancy outcomes in females after treatment for childhood cancer. Epidemiology 11(2):161–166

    Article  CAS  PubMed  Google Scholar 

  39. Kenney LB, Nicholson HS, Brasseux C, Mills JL, Robison LL, Zeltzer LK et al (1996) Birth defects in offspring of adult survivors of childhood acute lymphoblastic leukemia. A Childrens Cancer Group/National Institutes of Health Report. Cancer 78(1):169–176

    Article  CAS  PubMed  Google Scholar 

  40. Signorello LB, Mulvihill JJ, Green DM, Munro HM, Stovall M, Weathers RE et al (2010) Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study. Lancet 376(9741):624–630

    Article  PubMed  PubMed Central  Google Scholar 

  41. Winther JF, Olsen JH, Wu H, Shyr Y, Mulvihill JJ, Stovall M et al (2012) Genetic disease in the children of Danish survivors of childhood and adolescent cancer. J Clin Oncol 30:27

    Article  PubMed  Google Scholar 

  42. Signorello LB, Mulvihill JJ, Green DM, Munro HM, Stovall M, Weathers RE et al (2012) Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol 30(2):239

    Article  PubMed  Google Scholar 

  43. Boice JD Jr, Tawn EJ, Winther JF, Donaldson SS, Green DM, Mertens AC et al (2003) Genetic effects of radiotherapy for childhood cancer. Health Phys 85(1):65–80

    Article  CAS  PubMed  Google Scholar 

  44. van der Kooi AL, Brewster DH, Wood R, Nowell S, Fischbacher C, van den Heuvel-Eibrink MM et al (2018) Perinatal risks in female cancer survivors: a population-based analysis. PLoS One 13(8):e0202805

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Mueller BA, Chow EJ, Kamineni A, Daling JR, Fraser A, Wiggins CL et al (2009) Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis. Arch Pediatr Adolesc Med 163(10):879–886

    Article  PubMed  PubMed Central  Google Scholar 

  46. Critchley HO, Wallace WH (2005) Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 2005(34):64–68

    Article  Google Scholar 

  47. Black KZ, Nichols HB, Eng E, Rowley DL (2017) Prevalence of preterm, low birthweight, and small for gestational age delivery after breast cancer diagnosis: a population-based study. Breast Cancer Res 19(1):11

    Article  PubMed  PubMed Central  Google Scholar 

  48. Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB et al (2002) Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol 187(4):1070–1080

    Article  PubMed  Google Scholar 

  49. Cardoso F, Loibl S, Pagani O, Graziottin A, Panizza P, Martincich L et al (2012) The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer 48(18):3355–3377

    Article  PubMed  Google Scholar 

  50. Jatoi I, Chen BE, Anderson WF, Rosenberg PS (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25(13):1683–1690

    Article  PubMed  Google Scholar 

  51. Clark RM, Reid J (1978) Carcinoma of the breast in pregnancy and lactation. Int J Radiat Oncol Biol Phys 4(7–8):693–698

    Article  CAS  PubMed  Google Scholar 

  52. Clark RM, Chua T (1989) Breast cancer and pregnancy: the ultimate challenge. Clin Oncol 1(1):11–18

    Article  CAS  Google Scholar 

  53. Howard-Anderson J, Ganz PA, Bower JE, Stanton AL (2012) Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst 104(5):386–405

    Article  PubMed  Google Scholar 

  54. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH et al (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(19):2500

    Article  PubMed  PubMed Central  Google Scholar 

  55. Thewes B, Meiser B, Rickard J, Friedlander M (2003) The fertility-and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study. Psycho-Oncology 12(5):500–511

    Article  PubMed  Google Scholar 

  56. Schover LR, Rybicki LA, Martin BA, Bringelsen KA (1999) Having children after cancer: a pilot survey of survivors’ attitudes and experiences. Cancer 86(4):697–709

    Article  CAS  PubMed  Google Scholar 

  57. Duffy CM, Allen SM, Clark MA (2005) Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 23(4):766–773

    Article  PubMed  Google Scholar 

  58. Avis NE, Crawford S, Manuel J (2004) Psychosocial problems among younger women with breast cancer. Psycho-Oncology 13(5):295–308

    Article  PubMed  Google Scholar 

  59. Freedman RA, Partridge AH (2013) Management of breast cancer in very young women. Breast 22:S176–S179

    Article  PubMed  Google Scholar 

  60. Paluch-Shimon S, Pagani O, Partridge AH, Abulkhair O, Cardoso MJ, Dent RA et al (2017) ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). Breast 35:203–217

    Article  PubMed  Google Scholar 

  61. World Health Organization (2015) Medical eligibility criteria for contraceptive use, 5th edn. World Health Organization, Geneva

    Google Scholar 

  62. Mody SK, Panelli DM, Hulugalle A, Su HI, Gorman JR (2017) Contraception concerns, utilization and counseling needs of women with a history of breast cancer: a qualitative study. Int J Women’s Health 9:507–512

    Article  Google Scholar 

  63. Güth U, Huang DJ, Bitzer J, Tirri BF, Moffat R (2016) Contraception counseling for young breast cancer patients: a practical needs assessment and a survey among medical oncologists. Breast 30:217–221

    Article  PubMed  Google Scholar 

  64. International Collaborative Post-Marketing Surveillance of Norplant (2001) Post-marketing surveillance of Norplant contraceptive implants: IContraceptive efficacy and reproductive health. Contraception 63(4):167–186

    Article  Google Scholar 

  65. Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347(9017):1713–1727

    Article  Google Scholar 

  66. Pragout D, Laurence V, Baffet H, Raccah-Tebeka B, Rousset-Jablonski C (2018) Contraception et cancer. RPC Contraception CNGOF. Gynecol Obstet Fertil Senol 46(12):834–844

    CAS  PubMed  Google Scholar 

  67. Blanc B, Lazard A, Estrade JP, Agostini A, Gurriet B (2010) Contraceptive methods after gynecological and breast cancer. Bull Acad Natl Med 194(3):521–527

    PubMed  Google Scholar 

  68. Schwarz EB, Hess R, Trussell J (2009) Contraception for cancer survivors. J Gen Intern Med 24(2-Suppl):401–406

    Article  PubMed Central  Google Scholar 

  69. Cook-Andersen H, Komrokian S, DeMichele A, Su HI (2011) Breast cancer patients have lower rates of contraception use. Fertil Steril 96(3):S201–S202

    Article  Google Scholar 

  70. Dominick SA, McLean MR, Whitcomb BW, Gorman JR, Mersereau JE, Bouknight JM et al (2015) Contraceptive practices among female cancer survivors of reproductive age. Obstet Gynecol 126(3):498–507

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Hatcher R, Trussell J, Stewart F, Nelson A, Cates W, Guest F et al (2004) Contraceptive technology, 18th edn. Ardent Media, New York

    Google Scholar 

  72. Trussell J (2011) Contraceptive efficacy. In: Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar M (eds) Contraceptive technology, 20th edn. Ardent Media, New York

    Google Scholar 

  73. Thonneau PF, Almont T (2008) Contraceptive efficacy of intrauterine devices. Am J Obstet Gynecol 198(3):248–253

    Article  CAS  PubMed  Google Scholar 

  74. Mohllajee AP, Curtis KM, Peterson HB (2006) Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Contraception 73(2):145–153

    Article  PubMed  Google Scholar 

  75. Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, Whiteman MK (2016) US selected practice recommendations for contraceptive use

    Google Scholar 

  76. Van Houdenhoven K, Van Kaam KJ, Van Grootheest AC, Salemans TH, Dunselman GA (2006) Uterine perforation in women using a levonorgestrel-releasing intrauterine system. Contraception 73(3):257–260

    Article  PubMed  CAS  Google Scholar 

  77. United Nations Development Programme (1997) Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C. Contraception 56(6):341–352

    Google Scholar 

  78. Sivin I (2007) Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception 75(6-Suppl):S70–S75

    Article  CAS  PubMed  Google Scholar 

  79. Lockhat FB, Emembolu JE, Konje JC (2005) Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel. Fertil Steril 83(2):398–404

    Article  CAS  PubMed  Google Scholar 

  80. Trinh XB, Tjalma WA, Makar AP, Buytaert G, Weyler J, van Dam PA (2008) Use of the levonorgestrel-releasing intrauterine system in breast cancer patients. Fertil Steril 90(1):17–22

    Article  CAS  PubMed  Google Scholar 

  81. De Bock GH, Bonnema J, van Der Hage J, Kievit J, Van de Velde CJ (2004) Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol 22(19):4010–4018

    Article  PubMed  Google Scholar 

  82. Montgomery DA, Krupa K, Cooke TG (2007) Alternative methods of follow up in breast cancer: a systematic review of the literature. Br J Cancer 96(11):1625–1632

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Lu W, de Bock GH, Schaapveld M, Baas PC, Wiggers T, Jansen L (2011) The value of routine physical examination in the follow up of women with a history of early breast cancer. Eur J Cancer 47(5):676–682

    Article  PubMed  Google Scholar 

  84. Grunfeld E, Noorani H, McGahan L, Paszat L, Coyle D, Van Walraven C et al (2002) Surveillance mammography after treatment of primary breast cancer: a systematic review. Breast 11(3):228–235

    Article  CAS  PubMed  Google Scholar 

  85. Lash TL, Fox MP, Buist DS, Wei F, Field TS, Frost FJ et al (2007) Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol 25(21):3001–3006

    Article  PubMed  Google Scholar 

  86. Schootman M, Jeffe DB, Lian M, Aft R, Gillanders WE (2008) Surveillance mammography and the risk of death among elderly breast cancer patients. Breast Cancer Res Treat 111(3):489–496

    Article  PubMed  Google Scholar 

  87. Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL et al (2016) American cancer society/American society of clinical oncology breast cancer survivorship care guideline. J Clin Oncol 34(6):611–635

    Article  CAS  PubMed  Google Scholar 

  88. Montgomery DA, Krupa K, Cooke TG (2007) Alternative methods of follow up in breast cancer: a systematic review of the literature. Br J Cancer 96(11):1625–1632

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Rojas MP, Telaro E, Russo A, Moschetti I, Coe L, Fossati R et al (2005) Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 1:CD001768

    Google Scholar 

  90. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry. Cancer 109(9):1721–1728

    Article  PubMed  Google Scholar 

  91. Dawood S (2010) Triple-negative breast cancer: epidemiology and management options. Drugs 70(17):2247–2258

    Article  CAS  PubMed  Google Scholar 

  92. van Maaren MC, de Munck L, Strobbe LJ, Sonke GS, Westenend PJ, Smidt ML et al (2019) Ten-year recurrence rates for breast cancer subtypes in the Netherlands: a large population-based study. Int J Cancer 144(2):263–272

    Article  PubMed  CAS  Google Scholar 

  93. Johnson HM, Lewis TC, Mitchell KB (2020) Breast cancer screening during lactation: ensuring optimal surveillance for breastfeeding women. Obstet Gynecol 135(1):194–198

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Unit, Helios University Hospital, University Witten Herdecke, Wuppertal, Germany

    Vesna Bjelic-Radisic

  2. Department of Oncology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

    Mohsen Esfandbod

  3. Breast Disease Research Center (BDRC), Tehran University of Medical Sciences, Tehran, Iran

    Sadaf Alipour

  4. Department of Surgery, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

    Sadaf Alipour

Authors
  1. Vesna Bjelic-Radisic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohsen Esfandbod
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sadaf Alipour
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sadaf Alipour .

Editor information

Editors and Affiliations

  1. Breast Disease Research Center (BDRC), Tehran University of Medical Sciences, Tehran, Iran

    Sadaf Alipour

  2. Breast Disease Research Center (BDRC), Tehran University of Medical Sciences, Tehran, Iran

    Ramesh Omranipour

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bjelic-Radisic, V., Esfandbod, M., Alipour, S. (2020). Pregnancy in Breast Cancer Survivors. In: Alipour, S., Omranipour, R. (eds) Diseases of the Breast during Pregnancy and Lactation. Advances in Experimental Medicine and Biology, vol 1252. Springer, Cham. https://doi.org/10.1007/978-3-030-41596-9_23

Download citation

Publish with us

Policies and ethics

Search

Navigation